
Health and wellness company Mannatech's Q3 net sales down 8.1%

Mannatech reported a Q3 2025 net sales decline of 8.1% year-over-year, attributed to slowing regional demand. The company posted a net income of $1.9 million, a turnaround from a net loss last year, with a gross profit margin increase to 76.4% due to higher sales prices. However, trade policy changes and operational constraints may impact future profitability. Key metrics include Q3 sales of $29.16 million and a decrease in selling and administrative expenses.
)
Overview
- Mannatech Q3 2025 net sales decline 8.1% yr/yr due to slowing regional demand
- Co reports net income of $1.9 mln from a net loss last year
- Gross profit margin increases to 76.4% in Q3 2025 due to higher sales prices
Outlook
- Company notes trade policy changes could impact cost structure and profitability
- Company faces operational and supply chain constraints affecting cost mitigation
Result Drivers
- REGIONAL DEMAND - Slowing demand in certain regions contributed to 8.1% decline in net sales
- HIGHER SALES PRICES - Gross profit margin increased due to higher sales prices and lower inventory reserve additions
- COST REDUCTIONS - Selling and administrative expenses decreased due to reductions in payroll, travel, warehouse costs, and charitable contributions
Key Details
Metric Beat/Mis Actual Consensu
s s
Estimate
Q3 Sales $29.16
mln
Q3 Net $1.92
Income mln
Q3 Gross $22.27
Profit mln
Q3 $2.01
Income mln
from
Operatio
ns
Q3 $20.26
Operatin mln
g
Expenses
Q3 $2.51
Pretax mln
Profit
Press Release: For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact . (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

